Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 10/20 | 0.63 |
| ▸ | CALCR | P30988 | 10/20 | 0.63 |
| ▸ | NPY2R | P49146 | 8/20 | 0.60 |
| ▸ | NPY4R | P50391 | 8/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.60 |
| ▸ | NPY1R | P25929 | 6/20 | 0.60 |
| ▸ | EP300 | Q09472 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683337 | 0.95 | NPY2R (0.61) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29479782 | 0.94 | EP300 (0.60) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30277957 | 0.93 | NPY2R (0.58) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30429234 | 0.93 | EP300 (0.62) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30607296 | 0.93 | NPY2R (0.63) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30648440 | 0.92 | RAMP3 (0.65) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29827221 | 0.92 | NPY2R (0.59) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30906352 | 0.92 | NPY2R (0.59) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30712958 | 0.91 | NPY2R (0.60) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30974349 | 0.91 | RAMP3 (0.69) | RAMP3CALCRNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024020063-A2 | ANTI-HRF ANTIBODIES | LA JOLLA INSTITUTE FOR IMMUNOLOGY (US) | 2024-01-25 | — | — | WO | disclosed |